TRV GP IV, LLC's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Aug 1, 2024
- Accession no.
- 0000950170-24-089474
- Filed
- Aug 1, 2024, 5:51 PM ET
- Trade date
- Jul 30-Aug 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TRV GP IV, LLCCIK 0001688325 | 10% Owner |
| Third Rock Ventures GP IV, L.P.CIK 0001688326 | 10% Owner |
| Third Rock Ventures IV, L.P.CIK 0001688327 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | Common Stock | SSaleDisposed | −95,000 | $9.80 | −$931,114 | 17,626,475 | Direct | |
| Jul 31, 2024 | Common Stock | SSaleDisposed | −100,000 | $9.93 | −$993,380 | 17,526,475 | Direct | |
| Aug 1, 2024 | Common Stock | SSaleDisposed | −40,000 | $9.80 | −$392,000 | 17,486,475 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.